AIxCrypto Holdings Inc(AIXC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 23 at 4:56 PM ET (Korea 9/24 05:56)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -9.43 | Insider Own | 66.36% | Shs Outstand | 20.2M | Perf Week | 72.88% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 7.1M | Perf Month | 77.24% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | - | Inst Own | 2.7% | Short Float | 5.36% | Perf Quarter | 39.5% |
| Income | -0.03B | P/S | - | EPS this Y | - | Inst Trans | 2.69% | Short Ratio | 0.28 | Perf Half Y | 25.76% |
| Sales | 0.00B | P/B | 123.42 | EPS next 5Y | - | ROA | -402.99% | Short Interest | 0.38M | Perf YTD | -29.06% |
| Book/sh | 0.01 | P/C | 60.41 | EPS past 3/5Y | 67.79% 77.22% | ROE | -1136.66% | 52W High | -74.38% ($6.48) | Perf Year | -59.81% |
| Cash/sh | 0.03 | P/FCF | - | Sales past 3/5Y | - | ROIC | -403.06% | 52W Low | 179.93% ($0.59) | Perf 3Y | -96.75% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -8.71% | Gross Margin | - | Volatility(W/M) | 16.99% 16.43% | Perf 5Y | -99.77% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.19 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 3.68 | EPS Q/Q | 79.4% | Profit Margin | - | RSI (14) | 72.95 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.68 | Sales Q/Q | - | SMA20 | 76.28% ($0.94) | Beta | 0.53 | Target Price | $250 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/5/11 | SMA50 | 86.92% ($0.89) | Rel Volume | 0.69 | Prev Close | $1.41 |
| Employees | - | LT Debt/Eq | 0 | EPS/Sales Surpr. | 21.74% -100% | SMA200 | 18.49% ($1.4) | Avg Volume(3M) | 1.34M | Price | $1.66 |
| IPO | 2015/6/24 | Option/Short | No/Yes | Trades | 2563 | Volume | 916,973 | Change | 17.73% |
Company
AIXC is a Technology sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔗 AIxCrypto Holdings () is a digital asset platform company that combines AI with blockchain infrastructure. Originally a clinical-stage biotech company called Qualigen Therapeutics, it underwent a complete change in its name and business direction in November 2025. The company aims to build a blockchain ecosystem connected to real-world asset (RWA) tokenization, AI agents, and embodied AI.
Over the past 1 year, on the lower side
74% below its 1-year high.
AIXC has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Positive and negative signals are mixed
Tap to view numbers
Holding long would have lost money
Would have changed by -96.8% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 2.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
ITOT 0.00%
VXF 0.00%It ranks #4 in the industry
Based on market cap of $35M.
AIXC $35M PER -
MSFT $3.7T PER 27.9
PLTR $461B PER 163.4
ORCL $437B PER 22.7
FAQ
What kind of company is AIXC?
AIXC belongs to the Technology sector and operates in the Software - Infrastructure industry.
What is the market cap of AIXC?
The market cap of AIXC is approximately $35M, ranking 5,099 within its sector.
What is the 52-week high and low for AIXC?
AIXC has recorded a 52-week high of $6.48 and a low of $0.59.
